Skip to main content Scroll Top

Actualités

  • Accueil
  • Alzheimer
  • A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Posts les plus vus
Clear Filters
MedInTechs 2026 – Parc Floral de Paris | 9 & 10 MARS
MedInTechs 2026 – Parc Floral de Paris | 9 & 10 MARS
20 mars 2026
‘Beyond-the-brain’ strategy: a new photobiomodulation technique produces a neuroprotective effect in a mouse model of Alzheimer’s disease by synergistic mechanisms when targeting brain and guts
10 septembre 2019
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
11 juillet 2019
1 novembre 2022

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Read the article
JAD Journal of Alzheimer's Disease

Blivet G, Relano-Gines A, Wachtel M, Touchon J.

J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.

PMID: 36189591 Clinical Trial.

Partagez cet article